Literature DB >> 21333904

Potential biomarkers.

Robin C Spiller1.   

Abstract

A "biomarker" (biological marker) is an indicator of a bodily function that can be objectively measured. A wide range of possible biomarkers for IBS have been considered but at present only gut transit measured using radio-isotope markers meet the criteria of reproducibility and availability. While barostat studies perform reasonably in expert centers, to do them reproducibly requires considerable effort and standardization. This makes them unsuitable for widespread use. However radio-isotope tests are expensive and of limited availability so the search for other more convenient markers including blood and stool tests is still an important goal for the future.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21333904     DOI: 10.1016/j.gtc.2011.01.001

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  8 in total

1.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 2.  Neuroanatomy of lower gastrointestinal pain disorders.

Authors:  Wim Vermeulen; Joris G De Man; Paul A Pelckmans; Benedicte Y De Winter
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 3.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

4.  Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.

Authors:  William D Chey; Monthira Maneerattaporn; Richard Saad
Journal:  Gut Liver       Date:  2011-08-18       Impact factor: 4.519

5.  Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome.

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  Gastroenterol Res Pract       Date:  2014-06-16       Impact factor: 2.260

Review 6.  Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment.

Authors:  Robin Spiller
Journal:  F1000Res       Date:  2016-04-29

7.  Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome.

Authors:  Magdy El-Salhy; Odd Helge Gilja; Trygve Hausken
Journal:  Mol Med Rep       Date:  2014-08-08       Impact factor: 2.952

Review 8.  Serum biomarkers for irritable bowel syndrome.

Authors:  Alexandra Chira; Dan Lucian Dumitrascu
Journal:  Clujul Med       Date:  2015-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.